nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—MAPK14—Angiogenesis—TIMP2—intracranial aneurysm	0.0716	0.0828	CbGpPWpGaD
Celecoxib—MAPK14—Cardiac Progenitor Differentiation—SOX17—intracranial aneurysm	0.0323	0.0373	CbGpPWpGaD
Celecoxib—MAPK14—Amyotrophic lateral sclerosis (ALS)—CST3—intracranial aneurysm	0.0204	0.0236	CbGpPWpGaD
Celecoxib—PDPK1—VEGFR2 mediated vascular permeability—NOS3—intracranial aneurysm	0.0181	0.0209	CbGpPWpGaD
Celecoxib—PDPK1—VEGFR1 specific signals—NOS3—intracranial aneurysm	0.0176	0.0204	CbGpPWpGaD
Celecoxib—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC25A16—intracranial aneurysm	0.0175	0.0203	CbGpPWpGaD
Celecoxib—MAPK14—RANKL/RANK Signaling Pathway—CTSK—intracranial aneurysm	0.016	0.0186	CbGpPWpGaD
Celecoxib—PDPK1—VEGFA-VEGFR2 Pathway—NCF1—intracranial aneurysm	0.0149	0.0173	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by VEGF—NCF1—intracranial aneurysm	0.0141	0.0163	CbGpPWpGaD
Celecoxib—MAPK14—IL6-mediated signaling events—TIMP1—intracranial aneurysm	0.0138	0.0159	CbGpPWpGaD
Celecoxib—MAPK14—RAC1 signaling pathway—NCF1—intracranial aneurysm	0.0134	0.0155	CbGpPWpGaD
Celecoxib—PTGS2—Prostaglandin Synthesis and Regulation—EDNRA—intracranial aneurysm	0.0129	0.015	CbGpPWpGaD
Celecoxib—PDPK1—medulla oblongata—intracranial aneurysm	0.0124	0.0913	CbGeAlD
Celecoxib—PDPK1—BDNF signaling pathway—NCF1—intracranial aneurysm	0.0118	0.0136	CbGpPWpGaD
Celecoxib—MAPK14—AGE/RAGE pathway—NCF1—intracranial aneurysm	0.0114	0.0132	CbGpPWpGaD
Celecoxib—PDPK1—midbrain—intracranial aneurysm	0.0113	0.0834	CbGeAlD
Celecoxib—MAPK14—Endothelins—EDNRA—intracranial aneurysm	0.0112	0.0129	CbGpPWpGaD
Celecoxib—MAPK14—Angiogenesis—NOS3—intracranial aneurysm	0.0106	0.0123	CbGpPWpGaD
Celecoxib—ABCC4—Platelet degranulation—TIMP1—intracranial aneurysm	0.0103	0.0119	CbGpPWpGaD
Celecoxib—ABCC4—Response to elevated platelet cytosolic Ca2+—TIMP1—intracranial aneurysm	0.0098	0.0113	CbGpPWpGaD
Celecoxib—MAPK14—brainstem—intracranial aneurysm	0.00949	0.07	CbGeAlD
Celecoxib—PDPK1—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—intracranial aneurysm	0.0089	0.0103	CbGpPWpGaD
Celecoxib—PDPK1—cerebellum—intracranial aneurysm	0.00874	0.0645	CbGeAlD
Celecoxib—PDPK1—FGF signaling pathway—MMP9—intracranial aneurysm	0.00858	0.00993	CbGpPWpGaD
Celecoxib—MAPK14—Angiogenesis—MMP9—intracranial aneurysm	0.00853	0.00987	CbGpPWpGaD
Celecoxib—CA14—Metabolism—SLC25A16—intracranial aneurysm	0.00831	0.00961	CbGpPWpGaD
Celecoxib—MAPK14—Toll-Like Receptors Cascades—CTSS—intracranial aneurysm	0.00821	0.00949	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—SLC25A16—intracranial aneurysm	0.0081	0.00937	CbGpPWpGaD
Celecoxib—CA6—Metabolism—SLC25A16—intracranial aneurysm	0.0081	0.00937	CbGpPWpGaD
Celecoxib—MAPK14—VEGFA-VEGFR2 Pathway—NCF1—intracranial aneurysm	0.00776	0.00897	CbGpPWpGaD
Celecoxib—PDPK1—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.00769	0.00889	CbGpPWpGaD
Celecoxib—MAPK14—TWEAK Signaling Pathway—CCL2—intracranial aneurysm	0.00763	0.00882	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—SLC25A16—intracranial aneurysm	0.00756	0.00874	CbGpPWpGaD
Celecoxib—MAPK14—Toll-Like Receptors Cascades—CTSK—intracranial aneurysm	0.00755	0.00874	CbGpPWpGaD
Celecoxib—MAPK14—AGE/RAGE pathway—AGER—intracranial aneurysm	0.00741	0.00857	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by VEGF—NCF1—intracranial aneurysm	0.00732	0.00847	CbGpPWpGaD
Celecoxib—PDPK1—brain—intracranial aneurysm	0.0071	0.0524	CbGeAlD
Celecoxib—CA12—Metabolism—SLC25A16—intracranial aneurysm	0.007	0.0081	CbGpPWpGaD
Celecoxib—MAPK14—TRAF6 Mediated Induction of proinflammatory cytokines—AGER—intracranial aneurysm	0.00669	0.00774	CbGpPWpGaD
Celecoxib—CA14—medulla oblongata—intracranial aneurysm	0.00643	0.0475	CbGeAlD
Celecoxib—PTGS2—artery—intracranial aneurysm	0.00641	0.0473	CbGeAlD
Celecoxib—PDPK1—Signaling Pathways—STARD13—intracranial aneurysm	0.00632	0.00731	CbGpPWpGaD
Celecoxib—MAPK14—Angiopoietin receptor Tie2-mediated signaling—MMP2—intracranial aneurysm	0.00631	0.0073	CbGpPWpGaD
Celecoxib—PDPK1—Disease—SLC25A16—intracranial aneurysm	0.00626	0.00724	CbGpPWpGaD
Celecoxib—MAPK14—Toll-Like Receptors Cascades—CTSB—intracranial aneurysm	0.00625	0.00723	CbGpPWpGaD
Celecoxib—PDPK1—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.00619	0.00716	CbGpPWpGaD
Celecoxib—MAPK14—IL-1 signaling pathway—CCL2—intracranial aneurysm	0.00615	0.00711	CbGpPWpGaD
Celecoxib—MAPK14—BDNF signaling pathway—NCF1—intracranial aneurysm	0.00612	0.00708	CbGpPWpGaD
Celecoxib—MAPK14—MyD88 cascade initiated on plasma membrane—AGER—intracranial aneurysm	0.00605	0.007	CbGpPWpGaD
Celecoxib—PDPK1—CXCR4-mediated signaling events—MMP9—intracranial aneurysm	0.00603	0.00697	CbGpPWpGaD
Celecoxib—MAPK14—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—AGER—intracranial aneurysm	0.00599	0.00693	CbGpPWpGaD
Celecoxib—MAPK14—Angiopoietin receptor Tie2-mediated signaling—NOS3—intracranial aneurysm	0.00591	0.00684	CbGpPWpGaD
Celecoxib—MAPK14—MyD88 dependent cascade initiated on endosome—AGER—intracranial aneurysm	0.00589	0.00681	CbGpPWpGaD
Celecoxib—CA14—midbrain—intracranial aneurysm	0.00588	0.0434	CbGeAlD
Celecoxib—PDPK1—Signaling by VEGF—NOS3—intracranial aneurysm	0.00584	0.00676	CbGpPWpGaD
Celecoxib—MAPK14—Toll Like Receptor 9 (TLR9) Cascade—AGER—intracranial aneurysm	0.00568	0.00657	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.00561	0.00649	CbGpPWpGaD
Celecoxib—CA4—Metabolism—SLC25A16—intracranial aneurysm	0.00559	0.00646	CbGpPWpGaD
Celecoxib—MAPK14—MyD88:Mal cascade initiated on plasma membrane—AGER—intracranial aneurysm	0.00558	0.00646	CbGpPWpGaD
Celecoxib—MAPK14—ATF-2 transcription factor network—MMP2—intracranial aneurysm	0.00553	0.0064	CbGpPWpGaD
Celecoxib—CA14—Metabolism—ASAH1—intracranial aneurysm	0.0055	0.00637	CbGpPWpGaD
Celecoxib—MAPK14—TWEAK Signaling Pathway—MMP9—intracranial aneurysm	0.00545	0.00631	CbGpPWpGaD
Celecoxib—MAPK14—Thromboxane A2 receptor signaling—NOS3—intracranial aneurysm	0.0054	0.00625	CbGpPWpGaD
Celecoxib—MAPK14—Oncostatin M Signaling Pathway—CCL2—intracranial aneurysm	0.00538	0.00622	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—ASAH1—intracranial aneurysm	0.00536	0.0062	CbGpPWpGaD
Celecoxib—CA6—Metabolism—ASAH1—intracranial aneurysm	0.00536	0.0062	CbGpPWpGaD
Celecoxib—MAPK14—MyD88-independent cascade—AGER—intracranial aneurysm	0.00536	0.0062	CbGpPWpGaD
Celecoxib—CA2—Metabolism—SLC25A16—intracranial aneurysm	0.00535	0.00619	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—CTSS—intracranial aneurysm	0.00512	0.00592	CbGpPWpGaD
Celecoxib—MAPK14—AGE/RAGE pathway—MMP2—intracranial aneurysm	0.00506	0.00585	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—ASAH1—intracranial aneurysm	0.00501	0.00579	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—CTSS—intracranial aneurysm	0.00491	0.00568	CbGpPWpGaD
Celecoxib—MAPK14—Activated TLR4 signalling—AGER—intracranial aneurysm	0.00482	0.00557	CbGpPWpGaD
Celecoxib—CA9—cerebellum—intracranial aneurysm	0.0048	0.0354	CbGeAlD
Celecoxib—MAPK14—AGE/RAGE pathway—NOS3—intracranial aneurysm	0.00474	0.00548	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—CTSK—intracranial aneurysm	0.00471	0.00545	CbGpPWpGaD
Celecoxib—MAPK14—cerebellum—intracranial aneurysm	0.00468	0.0345	CbGeAlD
Celecoxib—ALB—Platelet degranulation—TIMP1—intracranial aneurysm	0.00466	0.00539	CbGpPWpGaD
Celecoxib—CA12—Metabolism—ASAH1—intracranial aneurysm	0.00464	0.00537	CbGpPWpGaD
Celecoxib—MAPK14—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—intracranial aneurysm	0.00462	0.00535	CbGpPWpGaD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.00456	0.00528	CbGpPWpGaD
Celecoxib—CA14—cerebellum—intracranial aneurysm	0.00455	0.0336	CbGeAlD
Celecoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—AGER—intracranial aneurysm	0.00453	0.00524	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—CTSK—intracranial aneurysm	0.00452	0.00523	CbGpPWpGaD
Celecoxib—CA9—Metabolism—SLC25A16—intracranial aneurysm	0.00451	0.00522	CbGpPWpGaD
Celecoxib—ABCC4—NRF2 pathway—AGER—intracranial aneurysm	0.00448	0.00519	CbGpPWpGaD
Celecoxib—MAPK14—FGF signaling pathway—MMP9—intracranial aneurysm	0.00446	0.00516	CbGpPWpGaD
Celecoxib—CA4—brainstem—intracranial aneurysm	0.00446	0.0329	CbGeAlD
Celecoxib—PDPK1—EGF/EGFR Signaling Pathway—NOS3—intracranial aneurysm	0.00444	0.00514	CbGpPWpGaD
Celecoxib—ALB—Response to elevated platelet cytosolic Ca2+—TIMP1—intracranial aneurysm	0.00444	0.00513	CbGpPWpGaD
Celecoxib—MAPK14—Leptin signaling pathway—NOS3—intracranial aneurysm	0.00428	0.00495	CbGpPWpGaD
Celecoxib—MAPK14—Platelet homeostasis—NOS3—intracranial aneurysm	0.00414	0.00479	CbGpPWpGaD
Celecoxib—MAPK14—Toll-Like Receptors Cascades—AGER—intracranial aneurysm	0.00404	0.00467	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.004	0.00462	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.00398	0.00461	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TIMP1—intracranial aneurysm	0.00396	0.00458	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—CTSB—intracranial aneurysm	0.0039	0.00451	CbGpPWpGaD
Celecoxib—MAPK14—AGE/RAGE pathway—MMP9—intracranial aneurysm	0.0038	0.00439	CbGpPWpGaD
Celecoxib—MAPK14—brain—intracranial aneurysm	0.0038	0.028	CbGeAlD
Celecoxib—PDPK1—Adaptive Immune System—CTSB—intracranial aneurysm	0.00374	0.00433	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—NCF1—intracranial aneurysm	0.00372	0.00431	CbGpPWpGaD
Celecoxib—CA4—Metabolism—ASAH1—intracranial aneurysm	0.0037	0.00428	CbGpPWpGaD
Celecoxib—CA14—brain—intracranial aneurysm	0.0037	0.0273	CbGeAlD
Celecoxib—CA2—brainstem—intracranial aneurysm	0.00369	0.0273	CbGeAlD
Celecoxib—MAPK14—Corticotropin-releasing hormone—NOS3—intracranial aneurysm	0.00363	0.0042	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.00358	0.00415	CbGpPWpGaD
Celecoxib—CA2—Metabolism—ASAH1—intracranial aneurysm	0.00355	0.0041	CbGpPWpGaD
Celecoxib—ALB—Vitamin B12 Metabolism—CCL2—intracranial aneurysm	0.00338	0.0039	CbGpPWpGaD
Celecoxib—ABCC4—Ectoderm Differentiation—CCL2—intracranial aneurysm	0.00336	0.00389	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—STARD13—intracranial aneurysm	0.00329	0.0038	CbGpPWpGaD
Celecoxib—MAPK14—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.00322	0.00372	CbGpPWpGaD
Celecoxib—CA4—medulla oblongata—intracranial aneurysm	0.00311	0.0229	CbGeAlD
Celecoxib—MAPK14—Signaling by VEGF—NOS3—intracranial aneurysm	0.00304	0.00351	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ASAH1—intracranial aneurysm	0.00299	0.00346	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CTSS—intracranial aneurysm	0.00298	0.00345	CbGpPWpGaD
Celecoxib—CA12—brain—intracranial aneurysm	0.00288	0.0213	CbGeAlD
Celecoxib—CA4—midbrain—intracranial aneurysm	0.00284	0.021	CbGeAlD
Celecoxib—ALB—Folate Metabolism—CCL2—intracranial aneurysm	0.00275	0.00318	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CTSK—intracranial aneurysm	0.00274	0.00317	CbGpPWpGaD
Celecoxib—PTGS2—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.0027	0.00312	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CTSS—intracranial aneurysm	0.00266	0.00308	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00259	0.00299	CbGpPWpGaD
Celecoxib—CA5B—brain—intracranial aneurysm	0.00259	0.0191	CbGeAlD
Celecoxib—CA2—medulla oblongata—intracranial aneurysm	0.00258	0.019	CbGeAlD
Celecoxib—PDPK1—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00257	0.00297	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—AGER—intracranial aneurysm	0.00252	0.00291	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CTSK—intracranial aneurysm	0.00245	0.00283	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CST3—intracranial aneurysm	0.0024	0.00277	CbGpPWpGaD
Celecoxib—CA2—midbrain—intracranial aneurysm	0.00235	0.0174	CbGeAlD
Celecoxib—ABCC4—Hemostasis—TIMP1—intracranial aneurysm	0.00235	0.00272	CbGpPWpGaD
Celecoxib—CYP2D6—brainstem—intracranial aneurysm	0.00235	0.0173	CbGeAlD
Celecoxib—PDPK1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00233	0.0027	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—NOS3—intracranial aneurysm	0.00231	0.00267	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CTSB—intracranial aneurysm	0.00227	0.00263	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—NCF1—intracranial aneurysm	0.00226	0.00261	CbGpPWpGaD
Celecoxib—CA4—cerebellum—intracranial aneurysm	0.0022	0.0162	CbGeAlD
Celecoxib—ALB—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.00218	0.00252	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—CCL2—intracranial aneurysm	0.00213	0.00247	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00209	0.00242	CbGpPWpGaD
Celecoxib—PDPK1—Disease—NCF1—intracranial aneurysm	0.00209	0.00241	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SLC25A16—intracranial aneurysm	0.00208	0.0024	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.00207	0.00239	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TIMP1—intracranial aneurysm	0.00206	0.00238	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CTSB—intracranial aneurysm	0.00203	0.00234	CbGpPWpGaD
Celecoxib—ALB—brain—intracranial aneurysm	0.00201	0.0148	CbGeAlD
Celecoxib—ABCC4—brain—intracranial aneurysm	0.00194	0.0143	CbGeAlD
Celecoxib—PTGS2—medulla oblongata—intracranial aneurysm	0.0019	0.014	CbGeAlD
Celecoxib—CA2—cerebellum—intracranial aneurysm	0.00182	0.0134	CbGeAlD
Celecoxib—PDPK1—Hemostasis—NOS3—intracranial aneurysm	0.00179	0.00207	CbGpPWpGaD
Celecoxib—CA4—brain—intracranial aneurysm	0.00178	0.0132	CbGeAlD
Celecoxib—PTGS2—Metabolism—SLC25A16—intracranial aneurysm	0.00174	0.00201	CbGpPWpGaD
Celecoxib—PTGS2—midbrain—intracranial aneurysm	0.00174	0.0128	CbGeAlD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00171	0.00198	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CTSS—intracranial aneurysm	0.00155	0.00179	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—MMP9—intracranial aneurysm	0.00152	0.00176	CbGpPWpGaD
Celecoxib—CA2—brain—intracranial aneurysm	0.00148	0.0109	CbGeAlD
Celecoxib—PDPK1—Immune System—AGER—intracranial aneurysm	0.00147	0.00169	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NCF1—intracranial aneurysm	0.00146	0.00169	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CTSK—intracranial aneurysm	0.00143	0.00165	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SLC25A16—intracranial aneurysm	0.00141	0.00163	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EDNRA—intracranial aneurysm	0.00138	0.00159	CbGpPWpGaD
Celecoxib—PTGS2—cerebellum—intracranial aneurysm	0.00134	0.00993	CbGeAlD
Celecoxib—MAPK14—Innate Immune System—AGER—intracranial aneurysm	0.00131	0.00151	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CTSB—intracranial aneurysm	0.00118	0.00136	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—NCF1—intracranial aneurysm	0.00117	0.00136	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SLC25A16—intracranial aneurysm	0.00116	0.00134	CbGpPWpGaD
Celecoxib—CYP2D6—cerebellum—intracranial aneurysm	0.00116	0.00854	CbGeAlD
Celecoxib—PTGS2—Metabolism—ASAH1—intracranial aneurysm	0.00115	0.00133	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SLC25A16—intracranial aneurysm	0.00115	0.00133	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—CCL2—intracranial aneurysm	0.00115	0.00133	CbGpPWpGaD
Celecoxib—CA14—Metabolism—NOS3—intracranial aneurysm	0.00115	0.00133	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—NOS3—intracranial aneurysm	0.00112	0.00129	CbGpPWpGaD
Celecoxib—CA6—Metabolism—NOS3—intracranial aneurysm	0.00112	0.00129	CbGpPWpGaD
Celecoxib—PTGS2—brain—intracranial aneurysm	0.00109	0.00806	CbGeAlD
Celecoxib—ALB—Hemostasis—TIMP1—intracranial aneurysm	0.00106	0.00123	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—NOS3—intracranial aneurysm	0.00106	0.00123	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—NOS3—intracranial aneurysm	0.00104	0.00121	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MMP2—intracranial aneurysm	0.00101	0.00117	CbGpPWpGaD
Celecoxib—CA12—Metabolism—NOS3—intracranial aneurysm	0.000968	0.00112	CbGpPWpGaD
Celecoxib—CYP2D6—brain—intracranial aneurysm	0.000939	0.00693	CbGeAlD
Celecoxib—ALB—Metabolism—ASAH1—intracranial aneurysm	0.000932	0.00108	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—NOS3—intracranial aneurysm	0.000928	0.00107	CbGpPWpGaD
Celecoxib—PDPK1—Disease—NOS3—intracranial aneurysm	0.000865	0.001	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CST3—intracranial aneurysm	0.000796	0.000921	CbGpPWpGaD
Celecoxib—CA4—Metabolism—NOS3—intracranial aneurysm	0.000772	0.000893	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ASAH1—intracranial aneurysm	0.00077	0.00089	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ASAH1—intracranial aneurysm	0.000763	0.000883	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—AGER—intracranial aneurysm	0.000761	0.000881	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC25A16—intracranial aneurysm	0.00076	0.000879	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MMP9—intracranial aneurysm	0.000759	0.000878	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NCF1—intracranial aneurysm	0.000759	0.000878	CbGpPWpGaD
Celecoxib—CA2—Metabolism—NOS3—intracranial aneurysm	0.00074	0.000856	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EDNRA—intracranial aneurysm	0.000717	0.000829	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NCF1—intracranial aneurysm	0.000692	0.000801	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CCL2—intracranial aneurysm	0.000679	0.000786	CbGpPWpGaD
Celecoxib—CA9—Metabolism—NOS3—intracranial aneurysm	0.000624	0.000722	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NOS3—intracranial aneurysm	0.000606	0.000701	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ASAH1—intracranial aneurysm	0.000503	0.000582	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MMP9—intracranial aneurysm	0.000486	0.000562	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NOS3—intracranial aneurysm	0.00048	0.000555	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCL2—intracranial aneurysm	0.000353	0.000408	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NOS3—intracranial aneurysm	0.000315	0.000364	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS3—intracranial aneurysm	0.000287	0.000332	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MMP9—intracranial aneurysm	0.000253	0.000292	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NOS3—intracranial aneurysm	0.00024	0.000278	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NOS3—intracranial aneurysm	0.000195	0.000225	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NOS3—intracranial aneurysm	0.000161	0.000186	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NOS3—intracranial aneurysm	0.000159	0.000184	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NOS3—intracranial aneurysm	0.000105	0.000121	CbGpPWpGaD
